On December 20, 2022, the Board of Directors of R1 RCM Inc. appointed Janie Wade as a director of the Company, effective January 1, 2023, to serve until the Company's 2023 Annual Meeting of Stockholders and thereafter until her successor is duly elected and qualified, or until her earlier death, resignation or removal. Pursuant to the Securities Purchase Agreement between the Company and IHC Health Services Inc. (Intermountain") dated January 23, 2018 (the Intermountain SPA"), and upon the recommendation of the Nominating and Corporate Governance Committee of the Board, Ms. Wade was appointed to the Board as the Investor Designee (as defined in the Intermountain SPA). Except for the Intermountain SPA, Ms. Wade was not selected pursuant to any arrangement or understanding between her and any other person.

Additional information about transactions between the Company and Intermountain is set out (i) under the heading Related Person Transactions Intermountain Transactions" in the Company's proxy statement/prospectus filed with the Securities and Exchange Commission (the SEC") on April 22, 2022 and (ii) under the headings Second Amended and Restated Registration Rights Agreement" and Warrant Assignment and Assumption Agreements.